Proteomic approaches to cancer target identification

Drug Discovery Today: Therapeutic Strategies

Volumn 4, Issue 4, 2007, Pages 245-250

  Cho, William C S ^a  

^a QUEEN ELIZABETH HOSPITAL   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

GEFITINIB; TUMOR MARKER; VINCRISTINE;

ANTINEOPLASTIC ACTIVITY; CANCER RESEARCH; CAPILLARY ELECTROPHORESIS; DRUG SENSITIVITY; EARLY DIAGNOSIS; ELECTROSPRAY MASS SPECTROMETRY; HUMAN; ION TRAP MASS SPECTROMETRY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MULTIDRUG RESISTANCE; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN MICROARRAY; PROTEIN TARGETING; PROTEOMICS; REVIEW; SENSITIVITY AND SPECIFICITY; SOLID TUMOR; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; TANDEM MASS SPECTROMETRY; TWO DIMENSIONAL GEL ELECTROPHORESIS;

EID: 46949090039     PISSN: 17406773     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ddstr.2008.02.007     Document Type: Review

References (35)

1. Dowling P., et al. 2-D difference gel electrophoresis of the lung squamous cell carcinoma versus normal sera demonstrates consistent alterations in the levels of ten specific proteins. Electrophoresis 28 (2007) 4302-4310
2. Aldini G., et al. Identification of actin as a 15-deoxy-Delta12,14-prostaglandin J2 target in neuroblastoma cells: mass spectrometric, computational, and functional approaches to investigate the effect on cytoskeletal derangement. Biochemistry 46 (2007) 2707-2718
3. Huang X., et al. Serum proteomics study of the squamous cell carcinoma antigen 1 in tongue cancer. Oral Oncol. 42 (2006) 26-31
4. Qi J., et al. Overexpression of sorcin in multidrug resistant human leukemia cells and its role in regulating cell apoptosis. Biochem. Biophys. Res. Commun. 349 (2006) 303-309
5. Flad T., et al. T cell epitope definition by differential mass spectrometry: identification of a novel, immunogenic HLA-B8 ligand directly from renal cancer tissue. Proteomics 6 (2006) 364-374
6. Khwaja F.W., et al. Attractin is elevated in the cerebrospinal fluid of patients with malignant astrocytoma and mediates glioma cell migration. Clin. Cancer Res. 12 (2006) 6331-6336
7. Stockwin L.H., et al. Proteomic analysis of plasma membrane from hypoxia-adapted malignant melanoma. J. Proteome Res. 5 (2006) 2996-3007
8. Kim Y.S., et al. Identification of target proteins of N-acetylglucosaminyl transferase V in human colon cancer and implications of protein tyrosine phosphatase kappa in enhanced cancer cell migration. Proteomics 6 (2006) 1187-1191
9. Yoshihara T., et al. Proteomic alteration in gastric adenocarcinomas from Japanese patients. Mol. Cancer 5 (2006) 75
10. Chen Y., et al. Proteomic analysis of EZH2 downstream target proteins in hepatocellular carcinoma. Proteomics 7 (2007) 3097-3104
11. Liu Y., et al. Identification of 14-3-3sigma as a contributor to drug resistance in human breast cancer cells using functional proteomic analysis. Cancer Res. 66 (2006) 3248-3255
12. Semba S., and Huebner K. Protein expression profiling identifies cyclophilin A as a molecular target in Fhit-mediated tumor suppression. Mol. Cancer Res. 4 (2006) 529-538
13. McClelland C.M., and Gullick W.J. Proteomic identification of secreted proteins as surrogate markers for signal transduction inhibitor activity. Br. J. Cancer 96 (2007) 284-289
14. Pei H., et al. Proteome analysis and tissue microarray for profiling protein markers associated with lymph node metastasis in colorectal cancer. J. Proteome Res. 6 (2007) 2495-2501
15. Bech-Serra J.J., et al. Proteomic identification of desmoglein 2 and activated leukocyte cell adhesion molecule as substrates of ADAM17 and ADAM10 by difference gel electrophoresis. Mol. Cell. Biol. 26 (2006) 5086-5095
16. Xiao G.S., et al. Annexin-I as a potential target for green tea extract induced actin remodeling. Int. J. Cancer 120 (2007) 111-120
17. Yang Y.X., et al. Proteome analysis of multidrug resistance in vincristine-resistant human gastric cancer cell line SGC7901/VCR. Proteomics 6 (2006) 2009-2021
18. Cho W.C. Research progress in SELDI-TOF MS and its clinical applications. Chin. J. Biotechnol. 22 (2006) 871-876
19. Cho W.C., et al. Identification of serum amyloid A protein as a potentially useful biomarker to monitor relapse of nasopharyngeal cancer by serum proteomic profiling. Clin. Cancer Res. 10 (2004) 43-52
20. Cho W.C., et al. Proteinchip array profiling for identification of disease- and chemotherapy-associated biomarkers of nasopharyngeal carcinoma. Clin. Chem. 53 (2007) 241-250
21. Bouamrani A., et al. Direct-tissue SELDI-TOF mass spectrometry analysis: a new application for clinical proteomics. Clin. Chem. 52 (2006) 2103-2106
22. Theodorescu D., et al. Discovery and validation of new protein biomarkers for urothelial cancer: a prospective analysis. Lancet Oncol. 7 (2006) 230-240
23. Ueda K., et al. Comparative profiling of serum glycoproteome by sequential purification of glycoproteins and 2-nitrobenzensulfenyl (NBS) stable isotope labeling: a new approach for the novel biomarker discovery for cancer. J. Proteome Res. 6 (2007) 3475-3483
24. Nielsen U.B., and Geierstanger B.H. Multiplexed sandwich assays in microarray format. J. Immunol. Methods 290 (2004) 107-120
25. Ivanov S.S., et al. Antibodies immobilized as arrays to profile protein post-translational modifications in mammalian cells. Mol. Cell. Proteomics 3 (2004) 788-795
26. Tibes R., et al. Reverse phase protein array: validation of a novel proteomic technology and utility for analysis of primary leukemia specimens and hematopoietic stem cells. Mol. Cancer Ther. 5 (2006) 2512-2521
27. Charboneau L., et al. Utility of reverse phase protein arrays: applications to signalling pathways and human body arrays. Brief Funct. Genomic Proteomic 1 (2002) 305-315
28. Gulmann C., et al. Array-based proteomics: mapping of protein in circuitries for diagnostics, prognostics, and therapy guidance in cancer. J. Pathol. 208 (2006) 595-606
29. Gembitsky D.S., et al. A prototype antibody microarray platform to monitor changes in protein tyrosine phosphorylation. Mol. Cell. Proteomics 3 (2004) 1102-1118
30. Song X.C., et al. Protein expression profiling of breast cancer cells by dissociable antibody microarray (DAMA) staining. Mol. Cell. Proteomics 7 (2008) 163-169
31. Cho W.C. Proteomics technologies and challenges. Genomics Proteomics Bioinformatics 5 (2007) 77-85
32. Kingsmore S.F. Multiplexed protein measurement: technologies and applications of protein and antibody arrays. Nat. Rev. Drug Discov. 5 (2006) 310-320
33. Cho W.C., and Cheng C.H. Oncoproteomics: current trends and future perspectives. Expert Rev. Proteomics 4 (2007) 401-410
34. Calvo K.R., et al. Clinical proteomics: from biomarker discovery and cell signaling profiles to individualized personal therapy. Biosci. Rep. 25 (2005) 107-125
35. Cho W.C. Contribution of oncoproteomics to cancer biomarker discovery. Mol. Cancer 6 (2007) 25